Health
Pfizer and BioNTech Announce Agreement with the United Kingdom for 30 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2 – Yahoo Finance
Thirty million doses expected to be delivered in 2020 and 2021, subject to regulatory approval or authorizationPfizer and BioNTech remain on track to begin an anticipated Phase.
- Thirty million doses expected to be delivered in 2020 and 2021, subject to regulatory approval or authorization
- Pfizer and BioNTech remain on track to begin an anticipated Phase 2b/3 safety and efficacy trial later this month, seek regulatory review as early as October 2020 and manufacture globally up to 100 million doses by the end of 2020 and more than 1.3 billion doses by the end of 2021
- Agreement is part of Pfizers and BioNTechs global commitment to help address the p…
Continue Reading
-
Noosa News22 hours agoSunshine Coast shines in tourism awards
-
General22 hours agoNational tax regulator shuts down Coolah firm and bans director after large-scale theft
-
General10 hours agoVote counting begins for Townsville mayoral by-election
-
General22 hours agoSwitzerland wins US tariff reduction to 15 per cent